Auranofin is an orally administered gold salt belonging to the disease-modifying antirheumatic drug (DMARD) class, primarily utilized to manage rheumatoid arthritis by reducing joint inflammation, pain,… Read more
Auranofin is an orally administered gold salt belonging to the disease-modifying antirheumatic drug (DMARD) class, primarily utilized to manage rheumatoid arthritis by reducing joint inflammation, pain, and stiffness. It functions by inhibiting thioredoxin reductase, a mechanism that modulates oxidative stress pathways involved in disease progression. To support the rigorous demands of pharmaceutical quality control, this category provides a comprehensive selection of reference standards, including the active pharmaceutical ingredient, its pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds. Pharmaceutical laboratories rely on these high-quality materials for impurity profiling, method validation, and accurate quantification during routine analysis. By utilizing these characterized reference materials, researchers can ensure compliance with regulatory standards and maintain the safety and efficacy of therapeutic formulations throughout the drug development lifecycle.